Skip to main content

DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients' airway epithelial cells.

EMBO molecular medicine2025-03-22PubMed
Total: 83.0Innovation: 9Impact: 8Rigor: 8Citation: 8

Summary

Using enzymatic methylome profiling and single-cell RNA-seq of nasal epithelium, the study identified 3,112 differentially methylated regions in COVID-19, with hypermethylation of ciliary genes that remained transcriptionally repressed in ciliated cells up to 12 months post-infection. An independent cohort validated symptom-dependent repression, implicating acute epigenetic changes in long-term airway dysfunction.

Key Findings

  • Identified 3,112 differentially methylated regions in nasal epithelial cells of COVID-19 patients versus controls.
  • Ciliary function genes were hypermethylated and remained transcriptionally repressed in ciliated cells up to 12 months post-infection.
  • An independent 6-month post-infection cohort validated symptom-dependent repression of ciliary genes.

Clinical Implications

Highlights mucociliary dysfunction as a target for monitoring and potential intervention in post-COVID care; motivates exploration of epigenetic-modifying or ciliary-supporting therapies.

Why It Matters

Provides mechanistic, cell-type–resolved evidence linking acute epigenetic alterations to prolonged ciliary dysfunction, a plausible driver of post-acute COVID-19 respiratory symptoms.

Limitations

  • Modest sample sizes limit generalizability and causal inference
  • Nasal epithelium may not fully represent lower airway biology; functional rescue experiments were not reported

Future Directions

Test reversibility of ciliary gene repression with epigenetic modulators, extend to lower airway samples, and correlate with longitudinal clinical phenotypes of post-COVID respiratory symptoms.

Study Information

Study Type
Cohort
Research Domain
Pathophysiology
Evidence Level
II - Prospective observational multi-omics analysis with longitudinal follow-up and external validation
Study Design
OTHER